CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations
Author
A Pardanani
A Tefferi
+36 more
A. M. Vannucchi
AJ Martí-Carvajal
AJ Mead
Al-AliHaifa Kathrin
AM Vannucchi
C Harrison
C Harrison
CN Harrison
D Atkins
D Colaizzo
DA Loblaw
F Cervantes
F Passamonti
F Passamonti
FR Lichtenberg
FR Lichtenberg
Ianotto JC1 F Boyer-Perrard
J Mehta
JJ Kiladjian
JT Reilly
K Gowin
M Sant
M Talpaz
NM Kroger
O Benjamini
PJ Ho
PL William
R Scherber
RA Mesa
RT Silver
S Galli
S Isfort
S Verstovsek
S Verstovsek
S Verstovsek
W Ageno
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref